» Articles » PMID: 33009369

Polygenic Risk Score, Psychosocial Environment and the Risk of Attention-deficit/hyperactivity Disorder

Abstract

The objective of the present study was to investigate whether the polygenic liability for attention-deficit/hyperactivity disorder (ADHD) and the psychosocial environment impact the risk of ADHD in interaction or independently of each other. We conducted a register- and biobank-based cohort study of 13,725 individuals with ADHD and 20,147 randomly drawn population-based controls. These 33,872 cohort members were genotyped on the Infinium PsychChip v1.0 array (Illumina). Subsequently, we calculated the polygenic risk score (PRS) for ADHD and extracted register data regarding the following risk factors pertaining to the psychosocial environment for each cohort member at the time of birth: maternal/paternal history of mental disorders, maternal/paternal education, maternal/paternal work status, and maternal/paternal income. We used logistic regression analyses to assess the main effects of the PRS for ADHD and the psychosocial environment on the risk of ADHD. Subsequently, we evaluated whether the effect of the PRS and the psychosocial environment act independently or in interaction upon the risk of ADHD. We found that ADHD was strongly associated with the PRS (odds ratio: 6.03, 95%CI: 4.74-7.70 for highest vs. lowest 2% liability). All risk factors pertaining to the psychosocial environment were associated with an increased risk of ADHD. These associations were only slightly attenuated after mutual adjustments. We found no statistically significant interaction between the polygenic liability and the psychosocial environment upon the risk of ADHD. In conclusion, we found main effects of both polygenic liability and risk factors pertaining to the psychosocial environment on the risk of ADHD-in the expected direction.

Citing Articles

Increasing specificity in ADHD genetic association studies during childhood: use of the oxytocin-vasopressin pathway in attentional processes suggests specific mechanism for endophenotypes in the 2004 Pelotas birth (Brazil) cohort.

Camerini L, Martins-Silva T, Rohde L, Santos I, Barros F, Genro J Eur Arch Psychiatry Clin Neurosci. 2025; .

PMID: 39934319 DOI: 10.1007/s00406-025-01968-3.


Gene - maltreatment interplay in adult ADHD symptoms: main role of a gene-environment correlation effect in a Brazilian population longitudinal study.

Tovo-Rodrigues L, Camerini L, Martins-Silva T, Carpena M, Bonilla C, Oliveira I Mol Psychiatry. 2024; 29(11):3412-3421.

PMID: 38744991 DOI: 10.1038/s41380-024-02589-3.


Joint polygenic and environmental risks for childhood attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom dimensions.

Mooney M, Ryabinin P, Morton H, Selah K, Gonoud R, Kozlowski M JCPP Adv. 2023; 3(2):e12152.

PMID: 37753156 PMC: 10519744. DOI: 10.1002/jcv2.12152.


Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use.

Sibeoni J, Manolios E, Hausser C, Delage R, Bayle F, Speranza M Sci Rep. 2023; 13(1):4040.

PMID: 36899043 PMC: 10006242. DOI: 10.1038/s41598-023-30921-4.


Hippocampal dentate gyri proteomics reveals Wnt signaling involvement in the behavioral impairment in the THRSP-overexpressing ADHD mouse model.

Custodio R, Kim H, Kim J, Ortiz D, Kim M, Buctot D Commun Biol. 2023; 6(1):55.

PMID: 36646879 PMC: 9842619. DOI: 10.1038/s42003-022-04387-5.


References
1.
Norgaard-Pedersen B, Hougaard D . Storage policies and use of the Danish Newborn Screening Biobank. J Inherit Metab Dis. 2007; 30(4):530-6. DOI: 10.1007/s10545-007-0631-x. View

2.
Breiderhoff T, Christiansen G, Pallesen L, Vaegter C, Nykjaer A, Holm M . Sortilin-related receptor SORCS3 is a postsynaptic modulator of synaptic depression and fear extinction. PLoS One. 2013; 8(9):e75006. PMC: 3777878. DOI: 10.1371/journal.pone.0075006. View

3.
Li J, Lee S . Interaction of dopamine transporter (DAT1) genotype and maltreatment for ADHD: a latent class analysis. J Child Psychol Psychiatry. 2012; 53(9):997-1005. PMC: 3445417. DOI: 10.1111/j.1469-7610.2012.02563.x. View

4.
Pedersen C, Mors O, Bertelsen A, Waltoft B, Agerbo E, McGrath J . A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry. 2014; 71(5):573-81. DOI: 10.1001/jamapsychiatry.2014.16. View

5.
. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511(7510):421-7. PMC: 4112379. DOI: 10.1038/nature13595. View